Suppr超能文献

埃塞俄比亚阿姆哈拉州北谢瓦地区德布雷伯尔汉综合专科医院艾滋病毒/艾滋病阳性和阴性女性宫颈癌前病变患病率及其相关因素:一项横断面研究

Prevalence of Precancerous Cervical Lesion and Its Associated Factors Among HIV/AIDS Positive and Negative Women in Debre Berhan Comprehensive Specialized Hospital, North Shewa Zone, Amhara Regional State, Ethiopia: A Cross-Sectional Study.

作者信息

Tesfahun Esubalew, Eshete Demsash, Abebe Zenebe, Hailemeskel Solomon

机构信息

School of Public Health Asrat Woldeyes Health Science Campus Debre Berhan University Debre Berhan Ethiopia.

School of Nursing and Midwifery Asrat Woldeyes Health Science Campus, Debre Berhan University Debre Berhan Ethiopia.

出版信息

Health Sci Rep. 2025 Aug 19;8(8):e71178. doi: 10.1002/hsr2.71178. eCollection 2025 Aug.

Abstract

BACKGROUND

Pre-invasive cervical lesion typically progresses for a considerable amount of time before developing into cervical cancer (CC). Consequently, early detection and treatment of cervical cancer at the pre-invasive stage may be advantageous to the patients and lessen the burden of morbidity and mortality from the disease. Our country has limited studies on Precancerous Cervical Lesions (PCCL).

AIMS

To assess the prevalence and associated factors of precancerous cervical lesions among HIV-positive and negative women in Debre Birhan Comprehensive Specialized Hospital, Ethiopia.

METHODS

An institutional-based comparative cross-sectional study was conducted from July/2021 to June/2023 among 522 women attending cervical cancer screening at Debre Birhan Comprehensive Specialized Hospital. All records during the study period were collected using a structured data extraction checklist. Binary logistic regression analyses were conducted to identify factors associated with pre-cancerous cervical lesions.

RESULTS

The overall prevalence of pre-cancerous cervical lesions was 8% (95% CI: 5.6-10.5. The prevalence of pre-cancerous cervical lesions in HIV-positive was 5.4% (95% CI: 2.8-.1) and in HIV-negative women 10.7% (95% CI: 5.6-8.1). Women with lifetime sexual partner ≥ 2 (AOR = 3.84, 95% CI: 1.06-3.97), who have a history of STI (AOR = 5.66, 95% CI: 1.50-21.41) and women with age ≥ 45 years (AOR = 4.22, 95% CI: 1.21-14.76) were contributing factors of a PCCL for HIV-positive women. In addition, women with a history of Sexually Transmitted Infection (STI) (AOR = 6.51, 95% CI: 2.11-0.09) and who have a lifetime sexual partner ≥ 2 (AOR = 8.4, 95% CI: 2.85-4.79) were statistically significant association with pre-cancerous cervical lesion for HIV-negative women.

CONCLUSION

The overall prevalence of pre-cancerous cervical lesions was found to be low in this study relative to the national prevalence. However, strengthening routine screening of women for pre-cancerous cervical lesions and behavioural change communication on risk factors is very important.

摘要

背景

宫颈浸润前病变通常在发展为宫颈癌(CC)之前会持续相当长一段时间。因此,在浸润前阶段早期发现和治疗宫颈癌可能对患者有利,并减轻该疾病的发病和死亡负担。我国对宫颈上皮内瘤变(PCCL)的研究有限。

目的

评估埃塞俄比亚德布雷伯尔汉综合专科医院艾滋病毒阳性和阴性女性中宫颈上皮内瘤变的患病率及相关因素。

方法

于2021年7月至2023年6月在德布雷伯尔汉综合专科医院对522名接受宫颈癌筛查的女性进行了一项基于机构的比较横断面研究。研究期间的所有记录均使用结构化数据提取清单收集。进行二元逻辑回归分析以确定与宫颈上皮内瘤变相关的因素。

结果

宫颈上皮内瘤变的总体患病率为8%(95%CI:5.6 - 10.5)。艾滋病毒阳性女性中宫颈上皮内瘤变的患病率为5.4%(95%CI:2.8 - 1.1),艾滋病毒阴性女性中为10.7%(95%CI:5.6 - 8.1)。终身性伴侣≥2名的女性(调整后比值比[AOR]=3.84,95%CI:1.06 - 3.97)、有性传播感染病史的女性(AOR = 5.66,95%CI:1.50 - 21.41)以及年龄≥45岁的女性(AOR = 4.22,95%CI:1.21 - 14.76)是艾滋病毒阳性女性发生宫颈上皮内瘤变的影响因素。此外,有性传播感染(STI)病史的女性(AOR = 6.51,95%CI:2.11 - 0.09)和终身性伴侣≥2名的女性(AOR = 8.4,95%CI:2.85 - 4.79)与艾滋病毒阴性女性的宫颈上皮内瘤变存在统计学上的显著关联。

结论

本研究中宫颈上皮内瘤变的总体患病率相对于全国患病率较低。然而,加强对女性宫颈上皮内瘤变的常规筛查以及关于危险因素的行为改变宣传非常重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa5d/12365001/56a85cb87a70/HSR2-8-e71178-g001.jpg

相似文献

3
Interventions targeted at women to encourage the uptake of cervical screening.
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
4
Strategies of testing for syphilis during pregnancy.
Cochrane Database Syst Rev. 2014 Oct 29;2014(10):CD010385. doi: 10.1002/14651858.CD010385.pub2.
10
Population-based biomedical sexually transmitted infection control interventions for reducing HIV infection.
Cochrane Database Syst Rev. 2011 Mar 16(3):CD001220. doi: 10.1002/14651858.CD001220.pub3.

本文引用的文献

3
Epidemiology of pre-cancerous cervical lesion and risk factors among adult women in Tigray, Ethiopia.
PLoS One. 2023 Jan 6;18(1):e0280191. doi: 10.1371/journal.pone.0280191. eCollection 2023.
4
Precancerous Lesion of the Cervix and Associated Factors Among Women of West Wollega, West Ethiopia, 2022.
Cancer Control. 2022 Jan-Dec;29:10732748221117900. doi: 10.1177/10732748221117900.
5
Prevalence and risk factors associated with precancerous cervical lesions among women in two cities in Cameroon.
Pan Afr Med J. 2022 Apr 6;41:276. doi: 10.11604/pamj.2022.41.276.21972. eCollection 2022.
6
Precancerous Lesions of the Cervix and Associated Factors among Women of East Gojjam, Northwest Ethiopia, 2020.
Cancer Manag Res. 2021 Dec 29;13:9401-9410. doi: 10.2147/CMAR.S338177. eCollection 2021.
7
Cervical Cancer Screening Guideline for Individuals at Average Risk.
JAMA. 2021 Dec 7;326(21):2193-2194. doi: 10.1001/jama.2021.13448.
10
Prevalence of precancerous cervical lesions in women attending Mezam Polyclinic Bamenda, Cameroon.
Pan Afr Med J. 2019 Apr 10;32:174. doi: 10.11604/pamj.2019.32.174.16895. eCollection 2019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验